about
High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and AtherosclerosisLipoprotein X Causes Renal Disease in LCAT DeficiencyLCAT deficiency does not impair amyloid metabolism in APP/PS1 miceHepatic ACAT2 knock down increases ABCA1 and modifies HDL metabolism in miceeNOS activation by HDL is impaired in genetic CETP deficiency.The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory propertiesGenetic determinants of HDL metabolism.Role of LCAT in Atherosclerosis.Lecithin:Cholesterol Acyltransferase Activation by Sulfhydryl-Reactive Small Molecules: Role of Cysteine-31.Fenofibrate and extended-release niacin improve the endothelial protective effects of HDL in patients with metabolic syndrome.Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome.Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency.Plasma-derived and synthetic high-density lipoprotein inhibit tissue factor in endothelial cells and monocytes.Paradoxical fall in proteinuria during pregnancy in an LCAT-deficient patient-A case reportAnti-Atherosclerotic Effect of a Polyphenol-Rich Ingredient, Oleactiv, in a Hypercholesterolemia-Induced Hamster ModelOff-target effects of thrombolytic drugs: apolipoprotein A-I proteolysis by alteplase and tenecteplaseDysfunctional HDL as a Therapeutic Target for Atherosclerosis PreventionComplete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With AtherosclerosisPlasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disordersA proteomic approach to identify novel disease biomarkers in LCAT deficiencyTopiramate protects apoE-deficient mice from kidney damage without affecting plasma lipidsAnalysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutationRecombinant LCAT (Lecithin:Cholesterol Acyltransferase) Rescues Defective HDL (High-Density Lipoprotein)-Mediated Endothelial Protection in Acute Coronary Syndrome
P50
Q26746080-00567720-AAF5-4BE6-903D-9669EC7CE4ECQ28550403-FDAAA1D2-25E5-4207-9A1D-8AE3989A13ADQ33945108-72C7F1FE-16D9-44C2-8B51-5F1449384A4CQ35138400-90DAD71D-6198-4909-893A-51356C9354B2Q35168995-53CB06AD-AE48-412F-ADA6-64AED50DFB65Q35994365-8CC676E9-9DE4-4E29-8C3A-0D20BA4DFC33Q38194237-D7DF7579-3AE1-4A47-9349-CFAE69ABD566Q38647735-E7A59F9D-2973-426D-9899-5EC6F28FCBB6Q38675396-816815F7-1C94-4FBC-80FA-1C69C0B18B44Q40777122-198E5B24-741A-47FA-A816-290B1490B52AQ44268118-80769C35-6543-44F1-A6B7-059D86343F52Q44430195-C9B3EACE-739F-4A6B-8567-CC811F064BCDQ51082527-DD5833A7-B879-4564-AB2B-800EA256AA51Q54234786-55ABD1FA-36A5-456F-A249-9FADBEFD7A6BQ57175164-32B47F6E-2509-4607-AA3B-8E156F94231AQ57464964-5C541CC9-48B7-4E41-B80B-6F814AF9D90DQ60727741-41C1EAE8-4A0C-4267-9926-0EDD6CD5E296Q88077084-14FF25A2-1701-400F-A7DC-45AD5E533C3BQ88632864-D91B7E7F-6F8B-4BF3-8951-541745211B92Q88934304-A60B8199-A866-4C59-88B5-94895970D2FFQ90359717-4DF0EFB0-41D5-4545-8448-97B311629B8BQ90799456-846132B8-B7CE-46D2-9C96-C74751B65AE6Q92335509-DA10EB82-CBC4-42D7-9BA9-D6F41993E8FEQ92508200-054E43BF-C002-4DCC-94CC-B325CA6A81EC
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alice Ossoli
@ast
Alice Ossoli
@en
Alice Ossoli
@es
Alice Ossoli
@nl
Alice Ossoli
@sl
type
label
Alice Ossoli
@ast
Alice Ossoli
@en
Alice Ossoli
@es
Alice Ossoli
@nl
Alice Ossoli
@sl
prefLabel
Alice Ossoli
@ast
Alice Ossoli
@en
Alice Ossoli
@es
Alice Ossoli
@nl
Alice Ossoli
@sl
P106
P1153
55534863600
P21
P31
P496
0000-0002-9902-252X